However, type I IFN locus deletions (42) as well as recurrent epigenetic silencing of the STING signaling pathway, which is essential for type I IFN-induction following radiotherapy (43, 44), have been reported in melanoma and might account for the observed intertumoral heterogeneity. The gene discussed is STING1; the disease is melanoma.